In:
Wiener klinische Wochenschrift, Springer Science and Business Media LLC, Vol. 135, No. S1 ( 2023-01), p. 32-44
Abstract:
Hyperglycemia significantly contributes to complications in patients with diabetes mellitus. While lifestyle interventions remain cornerstones of disease prevention and treatment, most patients with type 2 diabetes will eventually require pharmacotherapy for glycemic control. The definition of individual targets regarding optimal therapeutic efficacy and safety as well as cardiovascular effects is of great importance. In this guideline we present the most current evidence-based best clinical practice data for healthcare professionals.
Type of Medium:
Online Resource
ISSN:
0043-5325
,
1613-7671
DOI:
10.1007/s00508-023-02186-4
Language:
German
Publisher:
Springer Science and Business Media LLC
Publication Date:
2023
detail.hit.zdb_id:
2244243-1
Bookmarklink